Quantifying the clinical utility and cost-effectiveness of Next Gen Sequencing mutation panels for patients with indeterminate thyroid nodule cytology

  • Lee, James (Primary Chief Investigator (PCI))
  • Mond, Michael (Chief Investigator (CI))
  • Yannakou, Costas (Chief Investigator (CI))

Project: Research

StatusActive
Effective start/end date1/01/1931/12/21

Funding

  • The Aftershock: AUD220,000.00